{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:13:12Z","timestamp":1793297592538,"version":"4.5.0"},"reference-count":199,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Candida species, belonging to commensal microbial communities in humans, cause opportunistic infections in individuals with impaired immunity. Pathogens encountered in more than 90% cases of invasive candidiasis include C. albicans, C. glabrata, C. krusei, C. tropicalis, and C. parapsilosis. The most frequently diagnosed invasive infection is candidemia. About 50% of candidemia cases result in deep-seated infection due to hematogenous spread. The sensitivity of blood cultures in autopsy-proven invasive candidiasis ranges from 21% to 71%. Non-cultural methods (beta-D-glucan, T2Candida assays), especially beta-D-glucan in combination with procalcitonin, appear promising in the exclusion of invasive candidiasis with high sensitivity (98%) and negative predictive value (95%). There is currently a clear deficiency in approved sensitive and precise diagnostic techniques. Omics technologies seem promising, though require further development and study. Therapeutic options for invasive candidiasis are generally limited to four classes of systemic antifungals (polyenes, antimetabolite 5-fluorocytosine, azoles, echinocandins) with the two latter being highly effective and well-tolerated and hence the most widely used. Principles and methods of treatment are discussed in this review. The emergence of pan-drug-resistant C. auris strains indicates an insufficient choice of available medications. Further surveillance, alongside the development of diagnostic and therapeutic methods, is essential.<\/jats:p>","DOI":"10.3390\/antibiotics11060718","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:50:22Z","timestamp":1653555022000},"page":"718","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":179,"title":["Diagnosis and Treatment of Invasive Candidiasis"],"prefix":"10.3390","volume":"11","author":[{"given":"Natalia","family":"Barantsevich","sequence":"first","affiliation":[{"name":"Almazov National Madical Research Centre, Research Department of Microbiology and Nosocomial Indfections, Akkuratova, 2, 197341 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barantsevich","sequence":"additional","affiliation":[{"name":"Almazov National Madical Research Centre, Research Department of Microbiology and Nosocomial Indfections, Akkuratova, 2, 197341 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Romo, J.A., and Kumamoto, C.A. (2020). On commensalism of Candida. J. Fungi, 6.","DOI":"10.3390\/jof6010016"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mib.2020.05.006","article-title":"The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine","volume":"56","author":"Kumamoto","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151490","DOI":"10.1016\/j.ijmm.2021.151490","article-title":"Fungi of the human gut microbiota: Roles and significance","volume":"311","year":"2021","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bacali, C., Vulturar, R., Buduru, S., Cozma, A., Fodor, A., Chis, A., Lucaciu, O., Damian, L., and Moldovan, M.L. (2022). Oral microbiome: Metting to now and befriend neighbours, a biological approach. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030671"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hameed, S., Hans, S., Monasky, R., Thangamani, S., and Fatima, Z. (2021). Understanding human microbiota offers novel and promising therapeutic options against Candida infections. Pathogens, 10.","DOI":"10.3390\/pathogens10020183"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40168-021-01062-5","article-title":"Challenges in exploring and manipulating the human skin microbiome","volume":"9","author":"Boxberger","year":"2021","journal-title":"Microbiome"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2019.10.008","article-title":"Associations between the vaginal microbiome and Candida colonization in women of reproductive age","volume":"222","author":"Tortelli","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12934-020-01464-4","article-title":"Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health","volume":"19","author":"Chee","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","article-title":"Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: A critical review","volume":"19","author":"Kalia","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fcimb.2020.00081","article-title":"New insights in Candida albicans innate immunity at the mucosa: Toxins, epithelium, metabolism, and beyond","volume":"10","author":"Pellon","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MOP.0000000000000031","article-title":"Primary immunodeficiencies underlying fungal infections","volume":"25","author":"Lanternier","year":"2013","journal-title":"Curr. Opin. Pediatrics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108553","DOI":"10.1016\/j.clim.2020.108553","article-title":"Fungal infections in primary immunodeficiency diseases","volume":"219","author":"Meshaal","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1439-0507.2009.01785.x","article-title":"Incidence and predictors of invasive candidiasis associated with candidaemia in children","volume":"54","author":"Festekjian","year":"2011","journal-title":"Mycoses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/JCM.39.3.949-953.2001","article-title":"Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada","volume":"39","author":"Pelletier","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"204237","DOI":"10.1155\/2013\/204237","article-title":"Candida infections, causes, targets, and resistance mechanisms: Traditional and alternative antifungal agents","volume":"2013","author":"Spampinato","year":"2013","journal-title":"Biomed Res. Int."},{"key":"ref_17","first-page":"303","article-title":"Risk factors for non-albicans candidemia focusing on prior antifungal and immunosuppressive therapy","volume":"21","author":"Khoury","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive Candida infection in critically ill patients: A systematic review and meta-analysis","volume":"161","author":"Schlattmann","year":"2022","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/13693780802369332","article-title":"Candida bloodstream infections in hemodialysis recipients","volume":"47","author":"Pyrgos","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2011013","DOI":"10.4084\/mjhid.2011.013","article-title":"Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: Current epidemiology and therapeutic options","volume":"3","author":"Girmenia","year":"2011","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lin, Y.-L., Chen, I.-C., Yen, J.-H., Lai, C.-S., Tsai, Y.-C., Lu, C.-T., Wu, C.-Y., Lin, W.-S., Lin, C.-H., and Huang, Y.-C. (2022). Invasive Candidiasis in Hospitalized Patients with Major Burns. J. Pers. Med., 12.","DOI":"10.3390\/jpm12010047"},{"key":"ref_23","first-page":"389","article-title":"Candidemia and Invasive Candidiasis","volume":"35","author":"McCarty","year":"2021","journal-title":"Infect Dis. Clin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e036452","DOI":"10.1136\/bmjopen-2019-036452","article-title":"Risk of invasive candidiasis with prolonged duration of ICU stay: A systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"BMJ Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive candidiasis as a cause of sepsis in the critically ill patient","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Antonelli","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"a019778","DOI":"10.1101\/cshperspect.a019778","article-title":"The Candida pathogenic species complex","volume":"4","author":"Turner","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Papon, N., Courdavault, V., Clastre, M., and Bennett, R.J. (2013). Emerging and emerged pathogenic Candida species: Beyond the Candida albicans paradigm. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003550"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcimb.2020.00094","article-title":"Mechanisms of pathogenic Candida species to evade the host complement attack","volume":"10","author":"Singh","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13756-019-0534-2","article-title":"Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: A retrospective study from 2011 to 2017 in a teaching hospital in China","volume":"8","author":"Xiao","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a019745","DOI":"10.1101\/cshperspect.a019745","article-title":"Antifungal clinical trials and guidelines: What we know and do not know","volume":"4","author":"Pappas","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3389\/fmicb.2018.03081","article-title":"Candida auris: What have we learned about its mechanisms of pathogenicity?","volume":"9","author":"Rossato","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Du, H., Bing, J., Hu, T., Ennis, C.L., Nobile, C.J., and Huang, G. (2020). Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008921"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"759408","DOI":"10.3389\/fcimb.2021.759408","article-title":"Drug resistance and novel therapeutic approaches in invasive candidiasis","volume":"11","author":"Murphy","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12281-021-00420-y","article-title":"Candida auris: Diagnostic challenges and emerging opportunities for the clinical microbiology laboratory","volume":"15","author":"Keighley","year":"2021","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/myc.12904","article-title":"Candida auris\u2014The growing menace to global health","volume":"62","author":"Lone","year":"2019","journal-title":"Mycoses"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Garcia-Bustos, V., Cabanero -Navalon, M.D., Ruiz-Saur\u00ed, A., Ruiz-Gait\u00e1n, A.C., Salavert, M., Tormo, M.\u00c1., and Pem\u00e1n, J. (2021). What do we know about Candida auris? State of the art, knowledge gaps, and future directions. Microorganisms, 9.","DOI":"10.1128\/Spectrum.00013-21"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/myc.13223","article-title":"Activities of nine antifungal agents against Candida auris biofilms","volume":"64","author":"Chatzimoschou","year":"2021","journal-title":"Mycoses"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: The recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40588-020-00143-7","article-title":"Candida auris infection and biofilm formation: Going beyond the surface","volume":"7","author":"Horton","year":"2020","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.1021\/acsami.9b20708","article-title":"Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles","volume":"12","author":"Lara","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fmicb.2020.01535","article-title":"First genome sequences of two multidrug-resistant Candida haemulonii var. vulnera isolates from pediatric patients with candidemia","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3201\/eid2404.171715","article-title":"Candida auris infection leading to nosocomial transmission, Israel, 2017","volume":"24","author":"Belkin","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/mmy\/myy118","article-title":"Usefulness of guideline recommendations for prognosis in patients with candidemia","volume":"57","author":"Cuervo","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2147\/IDR.S323583","article-title":"Clinical features, strain distribution, antifungal resistance and prognosis of patients with non-albicans candidemia: A retrospective observational study","volume":"14","author":"Liu","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115509","DOI":"10.1016\/j.diagmicrobio.2021.115509","article-title":"Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients","volume":"101","author":"Carrano","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/0255-0857.99482","article-title":"Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods","volume":"30","author":"Ahmad","year":"2012","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Monday, L.M., Parraga Acosta, T., and Alangaden, G. (2021). T2Candida for the diagnosis and management of invasive Candida infections. J. Fungi, 7.","DOI":"10.3390\/jof7030178"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-021-00248-0","article-title":"Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia","volume":"11","author":"Sakai","year":"2021","journal-title":"J. Ophthal. Inflamm. Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.1989.00390100056014","article-title":"Prospective study of Candida endophthalmitis in hospitalized patients with candidemia","volume":"149","author":"Brooks","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"ref_54","first-page":"34","article-title":"Case report of invasive, disseminated candidiasis with peripheral nodular cavitary lesions in the lung","volume":"20","author":"Arshad","year":"2016","journal-title":"Respir. Med. Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chen, C.Y., Cheng, A., Tien, F.M., Lee, P.C., Tien, H.F., Sheng, W.H., and Chen, Y.C. (2019). Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4260-4"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ofid\/ofac088","article-title":"Hepatosplenic candidiasis in patients with hematological malignancies: A 13-year retrospective cohort study","volume":"9","author":"Boussen","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit. Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.12998\/wjcc.v7.i16.2374","article-title":"Treatment of invasive fungal disease: A case report","volume":"7","author":"Xiao","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Roberto, A., Xavier, D.E., Vidal, E.E., Vidal, C., Neves, R.P., and Lima-Neto, R.G. (2020). Rapid detection of echinocandins resistance by MALDI-TOF MS in Candida parapsilosis complex. Microorganisms, 8.","DOI":"10.3390\/microorganisms8010109"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of invasive fungal diseases: Summary of activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Shoham","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40121-019-0248-z","article-title":"Polymerase chain reaction versus blood culture to detect Candida species in high-risk patients with suspected invasive candidiasis: The MICAFEM Study","volume":"8","author":"Nieto","year":"2019","journal-title":"Infect. Dis. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2174\/1568026618666181025093146","article-title":"Diagnosis of invasive candidiasis: From gold standard methods to promising leading-edge technologies","volume":"18","author":"Pitarch","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Clancy, C.J., and Nguyen, M.H. (2018). Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences. J. Fungi, 4.","DOI":"10.3390\/jof4010027"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e01909-17","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing Invasive Candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2011.246","article-title":"ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia","volume":"47","author":"Arendrup","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: Systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Taira, C.L., Okay, T.S., Delgado, A.F., Ceccon, M.E., de Almeida, M.T., and Del Negro, G.M. (2014). A multiplex nested PCR for the detection and identification of Candida species in blood samples of critically ill paediatric patients. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-406"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Robinson, J.L., Davies, H.D., Barton, M., O\u2019Brien, K., Simpson, K., Asztalos, E., Synnes, A., Rubin, E., Le Saux, N., and Hui, C. (2009). Characteristics and outcome of infants with candiduria in neonatal intensive care\u2014A Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect. Dis., 9.","DOI":"10.1186\/1471-2334-9-183"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/jpids\/pix055","article-title":"Diagnostic imaging and invasive fungal diseases in children","volume":"6","author":"Katragkou","year":"2017","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/JOC.JOC_134_18","article-title":"Grocott methenamine silver positivity in neutrophils","volume":"36","author":"Adhya","year":"2019","journal-title":"J. Cytol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/cup.13769","article-title":"PAS and GMS utility in dermatopathology: Review of the current medical literature","volume":"47","author":"Shalin","year":"2020","journal-title":"J. Cutan. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: A clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jasc.2017.05.004","article-title":"Aberrant staining with Grocott\u2019s methenamine silver: Utility beyond fungal organisms","volume":"6","author":"Wright","year":"2017","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e00627","DOI":"10.1016\/j.idcr.2019.e00627","article-title":"Invasive candidiasis leading to gastric perforation in an immunocompromised patient","volume":"18","author":"Karasuno","year":"2019","journal-title":"IDCases"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Bhattacharya, S., Sae-Tia, S., and Fries, B.C. (2020). Candidiasis and mechanisms of antifungal resistance. Antibiotics, 9.","DOI":"10.3390\/antibiotics9060312"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: Results for Candida species from 1997\u20132016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Montes, K., Ortiz, B., Galindo, C., Figueroa, I., Braham, S., and Fontecha, G. (2019). Identification of Candida species from clinical samples in a honduran tertiary hospital. Pathogens, 8.","DOI":"10.20944\/preprints201909.0148.v1"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1128\/JCM.00213-06","article-title":"Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species","volume":"44","author":"Eraso","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2007.01872.x","article-title":"Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species","volume":"14","author":"Ghelardi","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/13693780802713224","article-title":"Performance of chromogenic Candida agar and CHROMagar Candida in recovery and presumptive identification of monofungal and polyfungal vaginal isolates","volume":"48","author":"Ozcan","year":"2010","journal-title":"Med. Mycol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Mulet Bayona, J.V., Salvador Garc\u00eda, C., Tormo Palop, N., Valent\u00edn Mart\u00edn, A., Gonz\u00e1lez Padr\u00f3n, C., Colomina Rodr\u00edguez, J., Pem\u00e1n, J., and Gimeno Cardona, C. (2022). Novel chromogenic medium CHROMagarTM Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental samples: A multicenter study. J. Fungi., 8.","DOI":"10.3390\/jof8030281"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"250408","DOI":"10.1155\/2014\/250408","article-title":"Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system","volume":"2014","author":"Kim","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jfma.2020.11.002","article-title":"High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods","volume":"120","author":"Huang","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/JCM.00938-16","article-title":"Identification and antifungal susceptibility profile of Candida guilliermondii and Candida fermentati from a multicenter study in China","volume":"54","author":"Cheng","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcimb.2019.00021","article-title":"Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a wide range of clinically isolated yeast species: Improved identification by combining 21-Plex PCR and API 20C AUX as an alternative strategy for developing countries","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Fasciana, T., Cortegiani, A., Ippolito, M., Giarratano, A., Di Quattro, O., Lipari, D., Graceffa, D., and Giammanco, A. (2020). Candida auris: An overview of how to screen, detect, test and control this emerging pathogen. Antibiotics, 9.","DOI":"10.3390\/antibiotics9110778"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/JCM.44.3.693-699.2006","article-title":"Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions","volume":"44","author":"Leaw","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Colabella, C., Casagrande Pierantoni, D., Corte, L., Roscini, L., Conti, A., Bassetti, M., Tascini, C., Robert, V., and Cardinali, G. (2021). Single strain high-depth NGS reveals high rDNA (ITS-LSU) variability in the four prevalent pathogenic species of the genus Candida. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020302"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmoldx.2012.02.004","article-title":"Evaluation of nucleic acid sequencing of the D1\/D2 region of the large subunit of the 28S rDNA and the internal transcribed spacer region using SmartGene IDNS [corrected] software for identification of filamentous fungi in a clinical laboratory","volume":"14","author":"Kwiatkowski","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1040638720905833","article-title":"Guidelines for Sanger sequencing and molecular assay monitoring","volume":"32","author":"Crossley","year":"2020","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"592588","DOI":"10.3389\/fgene.2020.592588","article-title":"Sanger validation of high-throughput sequencing in genetic diagnosis: Still the best practice?","volume":"11","author":"Kura","year":"2020","journal-title":"Front. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Chen, L., Cai, Y., Zhou, G., Shi, X., Su, J., Chen, G., and Lin, K. (2014). Rapid Sanger sequencing of the 16S rRNA gene for identification of some common pathogens. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088886"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eimc.2020.02.027","article-title":"MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory","volume":"39","year":"2021","journal-title":"Enferm. Infecc. Y Microbiol. Clin."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Robert, M.G., Cornet, M., Hennebique, A., Rasamoelina, T., Caspar, Y., Pond\u00e9rand, L., Bidart, M., Durand, H., Jacquet, M., and Garnaud, C. (2021). MALDI-TOF MS in a medical mycology maboratory: On stage and backstage. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061283"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijid.2020.09.1469","article-title":"In-house protocol and performance of MALDI-TOF MS in the early diagnosis of bloodstream infections in a fourth-level hospital in Colombia: Jumping to full use of this technology","volume":"101","author":"Cabrera","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.diagmicrobio.2012.01.013","article-title":"Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures","volume":"73","author":"Yaman","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Camp, I., Spettel, K., and Willinger, B. (2020). Molecular methods for the diagnosis of invasive candidiasis. J Fungi, 6.","DOI":"10.3390\/jof6030101"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study","volume":"149","author":"Wey","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365540903348336","article-title":"Typing of Candida isolates from patients with invasive infection and concomitant colonization","volume":"42","author":"Bergmann","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01763-15","article-title":"Posttreatment antifungal resistance among colonizing Candida isolates in candidemia patients: Results from a systematic multicenter study","volume":"60","author":"Jensen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"ofab080","DOI":"10.1093\/ofid\/ofab080","article-title":"Performance of repeated measures of (1-3)-\u03b2-D-Glucan, mannan antigen, and antimannan antibodies for the diagnosis of invasive candidiasis in ICU patients: A preplanned ancillary analysis of the EMPIRICUS randomized clinical trial","volume":"8","author":"Dupuis","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/mmy\/myy158","article-title":"Clinical value of (1,3)-\u03b2-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis","volume":"57","author":"Li","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13054-016-1324-3","article-title":"Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions","volume":"20","author":"Saavedra","year":"2016","journal-title":"Crit. Care"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1590\/s1678-9946202062025","article-title":"Performance of a new Candida anti-mannan IgM and IgG assays in the diagnosis of candidemia","volume":"62","author":"Meng","year":"2020","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Hanson, K.E., Pfeiffer, C.D., Lease, E.D., Balch, A.H., Zaas, A.K., Perfect, J.R., and Alexander, B.D. (2012). \u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: A randomized pilot study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042282"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","article-title":"\u03b2-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis","volume":"188","author":"Tissot","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11046-017-0238-1","article-title":"A Retrospective assessment of four antigen assays for the detection of invasive candidiasis among high-risk hospitalized patients","volume":"183","author":"Hartl","year":"2018","journal-title":"Mycopathologia"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01240-10","article-title":"Prospective survey of (1\u21923)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting","volume":"49","author":"Mohr","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/jac\/dkv241","article-title":"Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: A potential role in reducing the duration of treatment","volume":"70","author":"Valerio","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","article-title":"Combined use of serum (1,3)-\u03b2-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units","volume":"21","author":"Giacobbe","year":"2017","journal-title":"Crit. Care"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/jac\/dku225","article-title":"Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients","volume":"69","author":"Meije","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11046-017-0125-9","article-title":"Candida albicans germ-tube antibody: Evaluation of a new automatic assay for diagnosing invasive candidiasis in ICU patients","volume":"182","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/JCM.00609-11","article-title":"Quantitation of Candida CFU in initial positive blood cultures","volume":"49","author":"Pfeiffer","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/edn3.230","article-title":"Detection and survival of Candida albicans in soils","volume":"3","author":"Sautour","year":"2021","journal-title":"Environ. DNA"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Chang, S.S., Hsieh, W.H., Liu, T.S., Lee, S.H., Wang, C.H., Chou, H.C., Yeo, Y.H., Tseng, C.P., and Lee, C.C. (2013). Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis\u2014A systemic review and meta-analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062323"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Jordana-Lluch, E., Gim\u00e9nez, M., Quesada, M.D., Rivaya, B., Marc\u00f3, C., Dom\u00ednguez, M.J., Arm\u00e9star, F., Martr\u00f3, E., and Ausina, V. (2015). Evaluation of the broad-range PCR\/ESI-MS technology in blood specimens for the molecular diagnosis of bloodstream infections. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140865"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/JCM.01066-16","article-title":"Broad-Range PCR Coupled with electrospray ionization time of flight mass spectrometry for detection of bacteremia and fungemia in patients with neutropenic fever","volume":"54","author":"Desmet","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Metzgar, D., Frinder, M.W., Rothman, R.E., Peterson, S., Carroll, K.C., Zhang, S.X., Avornu, G.D., Rounds, M.A., Carolan, H.E., and Toleno, D.M. (2016). The IRIDICA BAC BSI assay: Rapid, sensitive and culture-independent identification of bacteria and candida in blood. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158186"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1128\/JCM.01135-14","article-title":"Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease","volume":"52","author":"White","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: A clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Krifors, A., Ullberg, M., Castegren, M., Petersson, J., Sparrelid, E., Hammarstr\u00f6m, H., Sj\u00f6lin, J., \u00d6zenci, V., and Blennow, O. (2022). T2Candida assay in the diagnosis of intraabdominal candidiasis: A prospective multicenter study. J. Fungi, 8.","DOI":"10.3390\/jof8010086"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Herman, A., and Herman, A.P. (2022). Could Candida Overgrowth Be Involved in the Pathophysiology of Autism?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020442"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Li, L., Liao, Z., Yang, Y., Lv, L., Cao, Y., and Zhu, Z. (2018). Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192328"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Liu, R., Bao, Z.X., Zhao, P.J., and Li, G.H. (2021). Advances in the study of metabolomics and metabolites in some species interactions. Molecules, 26.","DOI":"10.3390\/molecules26113311"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmicb.2016.00154","article-title":"An omics perspective on Candida infections: Toward next-generation diagnosis and therapy","volume":"7","author":"Smeekens","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/ncomms5675","article-title":"Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia","volume":"5","author":"Kumar","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_132","unstructured":"(2020). CLSI Performance Standards for Antifungal Susceptibility Testing of Yeasts, Clinical and Laboratory Standards Institute (CLSI). [2nd ed.]. CLSI supplement M60."},{"key":"ref_133","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2022, April 14). Breakpoint Tables for Interpretation of MICs for Antifungal Agents, Version 10.0. Available online: http:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e00069-19","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: Current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e02355-20","DOI":"10.1128\/JCM.02355-20","article-title":"Categorizing susceptibility of clinical isolates of Candida auris to amphotericin B, caspofungin, and fluconazole by use of the CLSI M44-A2 disk diffusion method","volume":"59","author":"Nunnally","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_136","unstructured":"CDC (2022, April 14). Antifungal Susceptibility Testing and Interpretation, Available online: https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-antifungal.html."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e00512-17","DOI":"10.1128\/AAC.00512-17","article-title":"Etest and Sensititre YeastOne susceptibility testing of echinocandins against Candida species from a single center in Austria","volume":"61","author":"Aigner","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3906\/sag-1909-97","article-title":"Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candida spp.","volume":"50","author":"Kiraz","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_139","first-page":"9","article-title":"Utilidad del panel Sensititre YeastOne\u00ae para detectar especies de Candida resistentes a los antif\u00fangicos [Usefulness of the Sensititre YeastOne\u00ae panel to detect Candida species resistant to antifungal drugs]","volume":"54","author":"Abiega","year":"2022","journal-title":"Rev. Argent. Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.riam.2017.11.001","article-title":"Evaluation of two commercial methods for the susceptibility testing of Candida species: Vitek 2\u00ae and Sensititre YeastOne\u00ae","volume":"35","author":"Siqueira","year":"2018","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e00485-17","DOI":"10.1128\/AAC.00485-17","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values","volume":"61","author":"Arendrup","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3201\/eid2007.131765","article-title":"Candida auris-associated candidemia, South Africa","volume":"20","author":"Magobo","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","article-title":"Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method","volume":"53","author":"Kathuria","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cmi.2018.05.012","article-title":"Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: A ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)","volume":"24","author":"Kritikos","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_145","first-page":"e20220","article-title":"Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution method and VITEK 2 automated antifungal susceptibility system for the determination of antifungal susceptibility of Candida species","volume":"13","author":"Ener","year":"2021","journal-title":"Cureus"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-016-1313-6","article-title":"Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy","volume":"20","author":"Calandra","year":"2016","journal-title":"Crit. Care"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/21505594.2020.1836902","article-title":"Candida albicans adhesion to central venous catheters: Impact of blood plasma-driven germ tube formation and pathogen-derived adhesins","volume":"11","author":"Jung","year":"2020","journal-title":"Virulence"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: Importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Vergidis, P., Clancy, C.J., Shields, R.K., Park, S.Y., Wildfeuer, B.N., Simmons, R.L., and Nguyen, M.H. (2016). Intra-abdominal candidiasis: The importance of early source control and antifungal treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153247"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Apsemidou, A., F\u00fcller, M.A., Idelevich, E.A., Kurzai, O., Tragiannidis, A., and Groll, A.H. (2020). Candida lusitaniae breakthrough fungemia in an immuno-compromised adolescent: Case report and review of the literature. J. Fungi, 6.","DOI":"10.3390\/jof6040380"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Faustino, C., and Pinheiro, L. (2020). Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010029"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Abdel-Hafez, Y., Siaj, H., Janajri, M., Abu-Baker, Y., Nazzal, Z., Hamdan, Z., Adwan, R., Aiesh, B.M., and Anaya, A.I. (2022). Tolerability and epidemiology of nephrotoxicity associated with conventional amphotericin B therapy: A retrospective study in tertiary care centers in Palestine. BMC Nephrol., 23.","DOI":"10.1186\/s12882-022-02770-2"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5114\/aoms.2020.93338","article-title":"Nephrotoxicity of three formulations of amphotericin B: Trial sequential analysis","volume":"16","author":"Caputo","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.burns.2019.09.001","article-title":"Burn patients with history of kidney transplant experience increased incidence of wound infection","volume":"46","author":"Zhang","year":"2020","journal-title":"Burns"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Peyclit, L., Yousfi, H., Rolain, J.-M., and Bittar, F. (2021). Drug repurposing in medical mycology: Identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi. Pharmaceuticals, 14.","DOI":"10.3390\/ph14050488"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Delma, F.Z., Al-Hatmi, A.M.S., Br\u00fcggemann, R.J.M., Melchers, W.J.G., de Hoog, S., Verweij, P.E., and Buil, J.B. (2021). Molecular mechanisms of 5-Fluorocytosine resistance in yeasts and filamentous fungi. J. Fungi, 7.","DOI":"10.3390\/jof7110909"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1517\/14656566.2015.1031108","article-title":"Advances in the treatment of invasive neonatal candidiasis","volume":"16","author":"Benjamin","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clp.2011.12.008","article-title":"The use of antifungal therapy in neonatal intensive care","volume":"39","author":"Testoni","year":"2012","journal-title":"Clin. Perinatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000007260","article-title":"Flucytosine: Correlation between toxicity and pharmacokinetic parameters","volume":"46","author":"Vermes","year":"2000","journal-title":"Chemotherapy"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Vitale, R.G. (2021). Role of antifungal combinations in difficult to treat Candida infections. J. Fungi, 7.","DOI":"10.3390\/jof7090731"},{"key":"ref_166","first-page":"43","article-title":"High prevalence of itraconazole resistance among Candida parapsilosis isolated from Iran","volume":"5","author":"Hassanmoghadam","year":"2019","journal-title":"Curr. Med. Mycol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Galia, L., Pezzani, M.D., Compri, M., Callegari, A., Rajendran, N.B., Carrara, E., Tacconelli, E., and The COMBACTE MAGNET EPI-Net Network (2022). Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries. J. Fungi, 8.","DOI":"10.3390\/jof8030249"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: A current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/fmb-2020-0217","article-title":"Rezafungin: A novel antifungal for the treatment of invasive candidiasis","volume":"16","author":"Ham","year":"2021","journal-title":"Future Microbiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e00546","DOI":"10.1002\/prp2.546","article-title":"Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK\/PD pharmacometrics of rezafungin efficacy","volume":"7","author":"Miesel","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e01992-20","DOI":"10.1128\/AAC.01992-20","article-title":"Efficacy of rezafungin in prophylactic mouse models of invasive Candidiasis, Aspergillosis, and Pneumocystis pneumonia","volume":"65","author":"Miesel","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e01556-19","DOI":"10.1128\/AAC.01556-19","article-title":"Determination of pharmacodynamic target exposures for rezafungin against Candida tropicalis and Candida dubliniensis in the neutropenic mouse disseminated candidiasis model","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e00099-20","DOI":"10.1128\/AAC.00099-20","article-title":"Activity of a long-acting echinocandin, rezafungin, and comparator antifungal agents tested against contemporary unvasive fungal isolates (SENTRY program, 2016 to 2018)","volume":"64","author":"Pfaller","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/21556660.2020.1734010","article-title":"Virtual screening for potential inhibitors of \u03b2(1,3)-D-glucan synthase as drug candidates against fungal cell wall","volume":"9","author":"Farhadi","year":"2020","journal-title":"J. Drug Assess."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins\u2014Structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Chmielewska","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e000837","DOI":"10.1136\/bmjophth-2021-000837","article-title":"Effect of first-line antifungal treatment on ocular complication risk in Candida or yeast blood stream infection","volume":"6","author":"Hautala","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.00945-09","article-title":"Effect of antifungal therapy timing on mortality in cancer patients with candidemia","volume":"54","author":"Taur","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Mroczy\u0144ska, M., and Brillowska-D\u0105browska, A. (2020). Review on current status of echinocandins use. Antibiotic, 9.","DOI":"10.3390\/antibiotics9050227"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"641965","DOI":"10.3389\/fmed.2021.641965","article-title":"No impact of fluconazole to echinocandins replacement as first-line therapy on the epidemiology of yeast fungemia (Hospital-Driven Active Surveillance, 2004\u20132017, Paris, France)","volume":"8","author":"Bretagne","year":"2021","journal-title":"Front. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2020.01.037","article-title":"Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis","volume":"93","author":"Bienvenu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Reboli, A.C., Shorr, A.F., Rotstein, C., Pappas, P.G., Kett, D.H., Schlamm, H.T., Reisman, A.L., Biswas, P., and Walsh, T.J. (2011). Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: A multivariate analysis of factors associated with improved outcome. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-261"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: A randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Vazquez, J., Reboli, A.C., Pappas, P.G., Patterson, T.F., Reinhardt, J., Chin-Hong, P., Tobin, E., Kett, D.H., Biswas, P., and Swanson, R. (2014). Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: Results from an open-label trial. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-97"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive candida infections: The ACTIVE trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: A propensity score analysis","volume":"58","author":"Aguado","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/myc.12641","article-title":"Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies","volume":"60","author":"Kontoyiannis","year":"2017","journal-title":"Mycoses"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/jac\/dkw305","article-title":"Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: A retrospective observational cohort study of the Mycoses Study Group (MSG-12)","volume":"71","author":"Chiotos","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/jac\/dkx116","article-title":"Efficacy of anidulafungin in 539 patients with invasive candidiasis: A patient-level pooled analysis of six clinical trials","volume":"72","author":"Kullberg","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a multidrug-resistant opportunistic fungal pathogen: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/IDR.S249864","article-title":"Candida auris: From multidrug resistance to pan-resistant strains","volume":"13","author":"Ademe","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"732223","DOI":"10.3389\/fcimb.2021.732223","article-title":"Antifungal Pipeline","volume":"11","author":"McCarty","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Wang, Q., Li, Y., Cai, X., Li, R., Zheng, B., Yang, E., Liang, T., Yang, X., Wan, Z., and Liu, W. (2021). Two sequential clinical isolates of Candida glabrata with multidrug-resistance to posaconazole and echinocandins. Antibiotics, 10.","DOI":"10.3390\/antibiotics10101217"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"myac008","DOI":"10.1093\/mmy\/myac008","article-title":"Emerging and future strategies in the management of recalcitrant Candida auris","volume":"60","author":"Bandara","year":"2022","journal-title":"Med. Mycol."},{"key":"ref_196","unstructured":"Centre for Disease Prevention and Control (2022). Candida auris Outbreak in Healthcare in Northern Italy, 2019\u20132021."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"\u010cern\u00e1kov\u00e1, L., Roudbary, M., Br\u00e1s, S., Tafaj, S., and Rodrigues, C.F. (2021). Candida auris: A quick review on identification, current treatments, and challenges. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094470"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ejhpharm-2020-002604","article-title":"Antifungal drug resistance: An update","volume":"29","author":"Denning","year":"2022","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/mmy\/myaa031","article-title":"Update on Candida krusei, a potential multidrug-resistant pathogen","volume":"59","author":"Jamiu","year":"2021","journal-title":"Med. Mycol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/6\/718\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:16Z","timestamp":1760138356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/6\/718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":199,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["antibiotics11060718"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11060718","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}